Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials Post author:Sam Post published:November 12, 2017 Post category:BioPharma Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace You Might Also Like 3 Drug Giants That Boasts the Best Pipelines April 9, 2017 Veracyte Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis May 18, 2017 JSR Life Sciences Snaps Up CRO in $400M Deal December 19, 2017
Veracyte Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis May 18, 2017